Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Rentokil
RTO
|
$510M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$205M |
| 3 |
TFI International
TFII
|
$146M |
| 4 |
Ambev
ABEV
|
$133M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
$132M |
Top Sells
| 1 |
Microsoft
MSFT
|
$8.38B |
| 2 |
Apple
AAPL
|
$5.18B |
| 3 |
Mastercard
MA
|
$3.67B |
| 4 |
Alphabet (Google) Class C
GOOG
|
$3.38B |
| 5 |
Amazon
AMZN
|
$3.16B |
Sector Composition
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.68% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2426
MiMedx Group
MDXG
$1.06B
| $40.9K | ﹤0.01% |
14,775
-14,775
| -50% | -$40.9K |
|
|
WW
2427
DELISTED
WW International
WW
| $40.6K | ﹤0.01% |
10,523
-10,523
| -50% | -$40.6K |
|
2428
Alto Ingredients
ALTO
$88.2M
| $40.3K | ﹤0.01% |
13,970
-13,974
| -50% | -$40.3K |
|
2429
Quantum-Si Incorporated
QSI
$215M
| $40K | ﹤0.01% |
22,044
-22,044
| -50% | -$40K |
|
2430
Sana Biotechnology
SANA
$746M
| $39.7K | ﹤0.01% |
10,075
-10,075
| -50% | -$39.7K |
|
2431
Amneal Pharmaceuticals
AMRX
$3.04B
| $39.2K | ﹤0.01% |
19,741
-19,739
| -50% | -$39.2K |
|
2432
Stitch Fix
SFIX
$732M
| $38K | ﹤0.01% |
12,240
-12,240
| -50% | -$38K |
|
2433
Energy Vault
NRGV
$324M
| $36.2K | ﹤0.01% |
11,605
-11,603
| -50% | -$36.1K |
|
2434
Workhorse Group
WKHS
$18.4M
| $33.8K | ﹤0.01% |
89
-90
| -50% | -$34.2K |
|
|
CTEV
2435
Claritev Corporation
CTEV
$1.2B
| $32.8K | ﹤0.01% |
715
-716
| -50% | -$32.8K |
|
|
LOGC
2436
DELISTED
ContextLogic
LOGC
| $32.6K | ﹤0.01% |
2,234
-2,233
| -50% | -$32.6K |
|
2437
Oscar Health
OSCR
$5.1B
| $31.8K | ﹤0.01% |
12,965
-12,965
| -50% | -$31.8K |
|
|
CANO
2438
DELISTED
Cano Health, Inc.
CANO
| $31.4K | ﹤0.01% |
230
-230
| -50% | -$31.4K |
|
2439
Angi Inc
ANGI
$823M
| $30.9K | ﹤0.01% |
1,308
-1,392
| -52% | -$32.9K |
|
|
AEVA
2440
Aeva Technologies
AEVA
$786M
| $30K | ﹤0.01% |
4,432
-4,435
| -50% | -$30.1K |
|
|
EGIO
2441
DELISTED
Edgio, Inc. Common Stock
EGIO
| $29.2K | ﹤0.01% |
643
-644
| -50% | -$29.2K |
|
2442
Humacyte
HUMA
$226M
| $27.7K | ﹤0.01% |
13,200
-13,836
| -51% | -$29K |
|
2443
Precigen
PGEN
$1.31B
| $27.2K | ﹤0.01% |
17,948
-17,948
| -50% | -$27.2K |
|
|
GOEV
2444
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $26.9K | ﹤0.01% |
48
-48
| -50% | -$26.9K |
|
|
RIDE
2445
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $26.8K | ﹤0.01% |
1,573
-1,572
| -50% | -$26.8K |
|
2446
Advantage Solutions
ADV
$596M
| $26K | ﹤0.01% |
12,532
-13,468
| -52% | -$27.9K |
|
|
HYZN
2447
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $25.3K | ﹤0.01% |
328
-346
| -51% | -$26.7K |
|
2448
Gossamer Bio
GOSS
$634M
| $21.9K | ﹤0.01% |
10,123
-10,121
| -50% | -$21.9K |
|
2449
Lexicon Pharmaceuticals
LXRX
$385M
| $21.6K | ﹤0.01% |
11,361
-11,361
| -50% | -$21.6K |
|
2450
Skillsoft
SKIL
$130M
| $16.3K | ﹤0.01% |
630
-681
| -52% | -$17.6K |
|